Application 220683
- Type
- ANDA
- Sponsor
- CAPLIN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SODIUM PHOSPHATES | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | SOLUTION;INTRAVENOUS | 1.34GM/5ML;1.38GM/5ML (268MG/ML; 276MG/ML) | No | No |
| 002 | SODIUM PHOSPHATES | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | SOLUTION;INTRAVENOUS | 4.02GM/15ML;4.14GM/15ML (268MG/ML; 276MG/ML) | No | No |
| 003 | SODIUM PHOSPHATES | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | SOLUTION;INTRAVENOUS | 13.4GM/50ML;13.8GM/50ML (268MG/ML; 276MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220683-001 | SODIUM PHOSPHATES | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 1.34GM/5ML;1.38GM/5ML (268MG/ML; 276MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-02-23 | |
| A220683-002 | SODIUM PHOSPHATES | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 4.02GM/15ML;4.14GM/15ML (268MG/ML; 276MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-02-23 | |
| A220683-003 | SODIUM PHOSPHATES | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 13.4GM/50ML;13.8GM/50ML (268MG/ML; 276MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-02-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220683-001 | AP |
| A220683-002 | AP |
| A220683-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220683-001 | SODIUM PHOSPHATES | 1.34GM/5ML;1.38GM/5ML (268MG/ML; 276MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-02-23 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220683-002 | SODIUM PHOSPHATES | 4.02GM/15ML;4.14GM/15ML (268MG/ML; 276MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-02-23 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220683-003 | SODIUM PHOSPHATES | 13.4GM/50ML;13.8GM/50ML (268MG/ML; 276MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-02-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220683-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220683-002 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220683-003 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SODIUM PHOSPHATES | SODIUM PHOSPHATES | GLENMARK PHARMACEUTICALS INC., USA | c968f70b-a670-4aef-a7e0-89468ad62d9c | 2026-03-12 | Warnings, Adverse reactions | 220683 ANDA220683 |
| SODIUM PHOSPHATES | SODIUM PHOSPHATES | Caplin Steriles Limited | 46de992b-5fc8-4dad-8d95-77938decb67e | 2026-03-10 | Warnings, Adverse reactions | 220683 ANDA220683 |